Skip to main content


Episode 45: Simplifying Biosimilars With Gary Lyman

December 31, 2019

Gary Lyman, MD, MPH, senior lead for quality and policy at the Hutchinson Institute for Cancer Outcomes Research, explains that it may take 8-12 years to prove that biosimilars should be trusted in everyday clinical practice, as well as delves into issues of granting extrapolation.

To watch Chadi discuss biosimilars at the most recent ASH Annual Meeting & Exposition, click here.

To watch Dr Lyman discuss biosimilars at the 2018 ASCO Annual Meeting, click here.

Dr Nabhan and Dr Lyman have no relevant financial disclosures.

Back to Top